Patent Assignment
Reel/Frame 035496/0382
Assignment of Assignor's Interest
Recorded: 2015-04-24
Pages: 11
Assignor
JANSSEN R & D IRELAND
Executed: 2014-12-29
Assignee
JANSSEN SCIENCES IRELAND UC
EASTGATE VILLAGE, EASTGATE, LITTLE ISLAND, CO. CORK, IRELAND
Covered Properties
(146)
2-Substituted Benzimidazoles
Homogeneous Time Resolved Fluorescence Based Test System for Paramyxoviridae
Prevention of Hiv-Infection
Application:
12/961,305 →
Publication:
US US20110077261A1
Hexahydrofuro'2,3-B!Furan-E-Yl-N{3'(1.3-Benzodioxol-5-Ylsulfonyl)Isobutyl)Amino!-1-Benzyl-2-Hydroxypropyl}Carbamate as Retroviral Protease Inhibitor
Patent:
6,649,651 →
Application:
10/089,991 →
Methods of Assessing Hiv Integrase Inhibitor Therapy
Method for the Preparation of Hexahydro-Furo-[2,3-B]Furan-3-Ol
Pseudopolymorphic Forms of a Hiv Protease Inhibitor
Microbicidal Pyrimidine or Triazine for Preventing Sexual Hiv Transmission
Hiv Replication Inhibiting Pyrimidines and Triazines
Hiv Replication Inhibiting Pyrimidines and Triazines
Morpholinyl Containing Benzimidazoles as Inhibitors of Respiratory Syncytial Virus Replication
Aminobenzimidazoles and Benzimidazoles as Inhibitors of Respiratory Syncytial Virus Replication
Piperdine-Amino-Benzimidazole Derivatives as Inhibitors of Respiratory Syncytial Virus Replication
Process for the Preparation of (3R,3AS,6AR)-Hexahydrofuro [2,3-B] Furan-3-Yl (1S,2R)-3-[[(4-Aminophenyl) Sulfonyl] (Isobutyl) Amino]-1-Benzyl-2-Hydroxypropylcarbamate
Methods for the Preparation of (3R,3AS,6AR) Hexahydro-Furo[2,3-B]Furan-3-Ol
Hexahydrofuro[2,3-B]Furan-3-Yl-N-{3-[(1,3-Benzodioxol-5-Ylsulfonyl)(Isobutyl)Amino]-1-Benzyl-2-Hydroxypropyl}Carbamate as Retroviral Protease Inhibitor
Methods of Assessing Hiv Integrase Inhibitor Therapy
(1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5H-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
Hiv Inhibiting 5-Heterocyclyl Pyrimidines
Hiv Inhibiting 5-Carbo-or Heterocyclic Substituted Pyrimidines
Hiv Inhibiting 5-Substituted Pyrimidines
Macrocyclic Inhibitors of Hepatitis C Virus
Hiv Inhibiting Bicyclic Pyrimdine Derivatives
Hiv Inhibiting 2-(4-Cyanophenylamino) Pyrimidine Oxide Derivatives
Protease Inhibitor Precursor Synthesis
1,3-Dihydro-Benzimidazol-2-Ylidene Amines as Inhibitors of Respiratory Syncytial Virus Replication
(1,10B-Dihydro-2-(Aminoalkyl-Phenyl)-5H-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
Use of a Sulfonamide Compound for Improving the Pharmacokinetics of a Drug
Process for Preparing 4-[(1,6-Dihydro-6-Oxo-2-Pyrimidinyl)Amino]Benzonitrile
Pyrido[2,3-D]Pyrimidines Useful as Hcv Inhibitors, and Methods for the Preparation Thereof
1-[[2-Amino-3-(Substituted Alkyl)-3H-Benzimidazolyl]Methyl]-3-Substituted-1,3-Dihydro-Benzoimidazol-2-Ones and Structural Analogs
Heterocyclylaminoalkyl Substituted Benzimidazoles
Macrocylic Inhibitors of Hepatitis C Virus
Macrocyclic Inhibitors of Hepatitis C Virus
Macrocyclic Inhibitors of Hepatitis C Virus
Macrocylic Inhibitors of Hepatitis C Virus
Macrocyclic Inhibitors of Hepatitis C Virus
Macrocyclic Inhibitors of Hepatitis C Virus
Macrocyclic Inhibitors of Hepatitis C Virus
Macrocylic Inhibitors of Hepatitis C Virus
Method and Means for Determining the Replication Rate of a Viral Population
Aminophenylsulfonamide Derivatives as Hiv Protease Inhibitor
Methods, Plasmid Vectors and Primers for Assessing Hiv Viral Fitness
Substituted Aminophenylsulfonamide Compounds as Hiv Protease Inhibitor
Morpholinyl Containing Benzimidazoles as Inhibitors of Respiratory Syncytial Virus Replication
Long Term Treatment of Hiv-Infection with TMC278
(1,10B-Dihydro-2-(Aminoalkyl-Phenyl)-5H-Pyrazolo[1,5 C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
5- or 6-Substituted Benzimidazole Derivatives as Inhibitors of Respiratory Syncytial Virus Replication
Hiv Inhibiting 5-Amido Substituted Pyrimidines
Hiv Inhibiting 5-(Hydroxymethylene and Aminomethylene) Substituted Pyrimidines
Lysine Related Derivatives as Hiv Aspartyl Protease Inhibitors
2-(Substituted-Amino)-Benzothiazole Sulfonamide Hiv Protease Inhibitors
Macrocyclic Inhibitors of Hepatitis C Virus
Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of Hcv
Carboxamide 4-[(4-Pyridyl)Amino] Pryimidines for the Treatment of Hepatitis C
Bioavailable Combinations for Hcv Treatment
Application:
12/445,039 →
Publication:
US US20120220520A1
Methods for the Preparation of Hexahydrofuro[2,3-B]Furan-3-Ol
Phenotype Prediction Method
Hydrobromide Salt of an Anti-Hiv Compound
Application:
12/517,665 →
Publication:
US US20100041687A1
Polymorphic Forms of a Macrocyclic Inhibitor of Hcv
Hiv Inhibiting 6-Substituted Pyrimidines
Hiv Inhibiting 5, 6-Substituted Pyrimidines
Hcv Inhibiting Macrocyclic Phenylcarbamates
Pyrimidine Substituted Macrocyclic Hcv Inhibitors
Powders for Reconstitution
Pseudopolymorphic Forms of a Hiv Protease Inhibitor
Process for Preparing Particles Containing an Antiviral
Combinations of a Pyrimidine Containing Nnrti with Rt Inhibitors
Crystalline Form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]-Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Hiv Inhibiting 2-(4-Cyanophenyl)-6-Hydroxylaminopyrimidines
Amide Compounds as Boosters of Antivirals
Macrocyclic Indoles as Hepatitis C Virus Inhibitors
Methods for Identifiying Inhibitors Against Viruses That Use a Class I Fusion Protein
Macrocyclic Indole Derivatives Useful as Hepatitis C Virus Inhibitors
Microbicidal Pyrimidine or Triazine for Preventing Sexual Hiv Transmission
Application:
13/043,174 →
Publication:
US US20110165093A1
Macrocyclic Indole Derivatives Useful as Hepatitis C Virus Inhibitors
Process for the Preparation of (3R,3AS,6AR)-Hexahydrofuro [2,3-B] Furan-3-Yl (1S,2R)-3-[[(4-Aminophenyl) Sulfonyl] (Isobutyl) Amino]-1-Benzyl-2-Hydroxypropylcarbamate
Macrocyclic Inhibitors of Hepatitis C Virus
Amide Compounds as Boosters of Antivirals
Implantable Devices for Treating Hiv
Application:
13/141,094 →
Publication:
US US20110256206A1
Macrocyclic Inhibitors of Hepatitis C Virus
Co-Crystal of Etravirine and Nicotinamide
Diaryl Ethers
Protease Inhibitor Precursor Synthesis
Method for Identifying Inhibitors Against Dengue Virus
Application:
13/319,724 →
Publication:
US US20120058920A1
Process for Preparing 4-[(1,6-Dihydro-6-Oxo-2-Pyrimidinyl)Amino]Benzonitrile
Phenyl Ethynyl Derivatives as Hepatitis C Virus Inhibitors
Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors
Process for Preparing Spray Dried Formulations of 4-[[6-Amino-5-Bromo-2-[(4-Cyanophenyl)Amino]-4-Pyrimidinyl]Oxy]-3,5-Dimethylbenzonitrile
Hiv Inhibiting Bicyclic Pyrimidine Derivatives
Patent:
9,487,518 →
Application:
13/410,779 →
Macrocyclic Inhibitors of Hepatitis C Virus
Macrocyclic Inhibitors of Hepatitis C Virus
Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of Hcv
Treatment and Prevention of Hiv Infection
Application:
13/497,719 →
Publication:
US US20120201868A1
Benzimidazole-imidazole Derivatives
Predictive Value of IL28B Gene Polymorphism Combined with Pretreatment Serum IP-10 Quantification for Response to Peginterferon and Ribavirin Is Enhanced in Comparison with any of these Biomarkers alone
Application:
13/514,193 →
Publication:
US US20120252695A1
5-Amino-4-Hydroxypentoyl Amides
Degradable Removable Implant for the Sustained Release of an Active Compound
Computation of the Combined Potency of Drug Regimens from Fitted or in Vitro Determined Dose-Response Curves
Application:
13/576,726 →
Publication:
US US20120310616A1
Macrocyclic Integrase Inhibitors
Macrocyclic Inhibitors of Hepatitis C Virus
Preparation of 13-Cyclohexyl-3-Methoxy-6-[Methyl-(2-{2-[Methyl-(Sulphamoyl)-Amino]-Ethoxy}-Ethyl)-Carbamoyl]-7H-Indolo-[2,1-a]-[2]-Benzazepine-10-Carboxylic Acid
Hetero-Bicyclic Derivatives as HCV Inhibitors
Macrocyclic Inhibitors of Hepatitis C Virus
Macrocyclic Indole Derivatives Useful as Hepatitis C Virus Inhibitors
Benzimidazole-imidazole derivatives
Macrocyclic Indoles as Hepatitis C Virus Inhibitors
Therapeutic Compositions Comprising Rilpivirine Hcl and Tenofovir Disoproxil Fumarate
Benzimidazole Respiratory Syncytial Virus Inhibitors
Azabenzimidazoles as Respiratory Syncytial Virus Antiviral Agents
Indoles as Respiratory Syncytial Virus Antiviral Agents
Azaindoles as Respiratory Syncytial Virus Antiviral Agents
Imidazopyridines as Respiratory Syncytial Virus Antiviral Agents
Pteridines Useful As HCV Inhibitors And Methods For The Preparation Thereof
Pyrimidine Derivatives for the Treatment of Viral Infections
Quinazoline Derivatives for the Treatment of Viral Infections and Further Diseases
Darunavir Formulations
Application:
14/131,272 →
Publication:
US US20140142174A1
Darunavir Combination Formulations
Application:
14/131,282 →
Publication:
US US20140142070A1
Macrocyclic Inhibitors of Hepatitis C Virus
Pseudopolymorphic Forms Of A HIV Protease Inhibitor
Application:
14/183,712 →
Publication:
US 2014/0171499
Antibacterial Homopiperidinyl Substituted 3,4-Dihydro-1H-[1,8]Naphthyridinones
Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones
Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
Macrocyclic Inhibitors Of Hepatitis C Virus
Degradable Removable Implant for the Sustained Release of An Active Compound
Purine derivatives for the treatment of viral infections
HIV Membrane Fusion Inhibitors
Application:
14/367,197 →
Publication:
US US20140357577A1
Hetero-Bicyclic Derivatives As HCV Inhibitors
Substituted Quinazolinones as Hcv Inhibitors
4,4-Disubstituted-1,4-Dihydropyrimidines and the Use Thereof as Medicaments for the Treatment of Hepatitis B
Piperidino-pyrimidine derivatives for the treatment of viral infections
Pyrimidine Derivatives for the Treatment of Bacterial Diseases
Polyinosinic-Polycytidylic Acid (Poly (I:C)) Formulations for the Treatment of Upper Respiratory Tract Infections
Uracyl Spirooxetane Nucleosides
4-Substituted 1,3-Dihydro-2H-Benzimidazol-2-One Derivatives Substituted with Benzimidazoles as Respiratory Syncytial Virus Antiviral Agents
Application:
14/407,109 →
Publication:
US US20150175608A1
Novel 1,3-Dihydro-2H-Benzimidazol-2-One Derivatives Substituted with Heterocycles as Respiratory Syncytial Virus Antiviral Agents
Application:
14/407,134 →
Publication:
US US20150111868A1
Novel 1,3-Dihydro-2H-Benzimidazol-2-One Derivatives Substituted with Benzimidazoles as Respiratory Syncytial Virus Antiviral Agents
Application:
14/407,155 →
Publication:
US US20150166533A1
1,3-Dihydro-2H-Benzimidazol-2-One Derivatives Substituted with Heterocycles as Respiratory Syncytial Virus Antiviral Agents
Application:
14/407,172 →
Publication:
US US20150158862A1
Macrocyclic Purines for the Treatment of Viral Infections
Combinations of A Pyrimidine Containing NNRTI with RT Inhibitors
Application:
14/454,045 →
Publication:
US US20140349971A1
Aqueous Suspensions of TMC278
Application:
14/493,525 →
Publication:
US US20150010637A1
Azabenzimidazoles as Respiratory Syncytial Virus Antiviral Agents
Indoles as Respiratory Syncytial Virus Antiviral Agents
Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
Hiv Inhibiting 5-Amido Substituted Pyrimidines
Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2004
From: KESTELEYN, BART RUDOLF ROMANIE; SURLERAUX, DOMINIQUE LOUIS NESTOR
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 015639/0601 →
Assignment of Assignor's Interest
May 24, 2005
From: VAN ROEY, JENS MARCEL; T.M.M.G. DE BETHUNE, MARIE-PIERRE; STOFFELS, PAUL
To: TIBOTEE PHARMACEUTICALS LTD.
Reel/Frame 016273/0223 →
Assignment of Assignor's Interest
Aug 12, 2005
From: HERTOGS, KURT; BETTENS, EVA
To: TIBOTEC BVBA
Reel/Frame 017590/0243 →
Assignment of Assignor's Interest
Aug 12, 2005
From: HEERES, JAN; LEWI, PAULUS JOANNES; DE JONGE, MARC RENE; KOYMANS, LUCIEN MARIA HENRICUS
To: JANSSEN PHARMACEUTICA N.V.
Reel/Frame 017604/0497 →
Assignment of Assignor's Interest
Aug 12, 2005
From: HERTOGS, KURT; BETTENS, EVA
To: TIBOTEC BVBA
Reel/Frame 017570/0990 →
Assignment of Assignor's Interest
Aug 12, 2005
From: GUILLEMONT, JEROME EMILE GEORGES; PASQUIER, ELISABETH THERESE JEANNE
To: JANSSEN-CILAG
Reel/Frame 017609/0155 →
Assignment of Assignor's Interest
Aug 12, 2005
From: GUILLEMONT, JEROME EMILE GEORGES; PASQUIER, ELISABETH THERESE JEANNE
To: JANSSEN-CILAG
Reel/Frame 017570/0987 →
Assignment of Assignor's Interest
Sep 1, 2005
From: VAN ROEY, JENS MARCEL; DE BETHUNE, MARIE-PIERRE T.M.M.G.; STOFFELS, PAUL
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 016704/0525 →
Re-Record to Correct the Address of the Assignee, Previously Recorded on Reel 016704 Frame 0525.
Dec 6, 2005
From: VAN ROEY, JENS MARCEL; DE BETHUNE, MARIE-PIERRE T.M.M.G.; STOFFELS, PAUL
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 017091/0759 →
Assignment of Assignor's Interest
Mar 6, 2006
From: QUAEDFLIEG, PETER JAN LEONARD MARIO
To: DSM IP ASSETS B.V.
Reel/Frame 017258/0727 →
Assignment of Assignor's Interest
Sep 11, 2006
From: DSM IP ASSETS B.V.
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 018225/0592 →
Assignment of Assignor's Interest
Jan 22, 2007
From: VINGERHOETS, JOHAN HENDRIKA JOZEF, MR.; MICHIELS, LIEVE EMMA JAN, MISS; DIERYNCK, INGE, MISS
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 018785/0129 →
Assignment of Assignor's Interest
Feb 14, 2008
From: BONFANTI, JEAN-FRANCOIS; ANDRIES, KOENRAAD JOZEF LODEWIJK MARCEL; JANSSENS, FRANS EDUARD; SOMMEN, FRANCOIS MARIA
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 020509/0721 →
Assignment of Assignor's Interest
May 5, 2008
From: JANSSEN PHARMACEUTICA N.V.
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 020902/0460 →
Assignment of Assignor's Interest
May 5, 2008
From: HEERES, JAN; LEWI, PAULUS JOANNES; DEJONGE, MARC RENE; KOYMANS, LUCIEN MARIA HENRICUS
To: JANSSEN PHARMACEUTICA, N.V.
Reel/Frame 020898/0726 →
Assignment of Assignor's Interest
May 5, 2008
From: JANSSEN-CILAG
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 020902/0454 →
Assignment of Assignor's Interest
May 5, 2008
From: TIBOTEC BVBA
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 020902/0458 →
Assignment of Assignor's Interest
May 18, 2008
From: TIBOTEC BVBA
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 020962/0307 →
Assignment of Assignor's Interest
May 18, 2008
From: JANSSEN-CILAG
To: TIBOTEC PHARMACEUTICALS LTD
Reel/Frame 020962/0305 →
Assignment of Assignor's Interest
May 18, 2008
From: JANSSEN PHARMACEUTICA N.V.
To: TIBOTEC PHARMACEUTICALS LTD
Reel/Frame 020962/0303 →
Assignment of Assignor's Interest
May 21, 2008
From: BONFANTI, JEAN FRANCOIS; FORTIN, JEROME MICHEL CLAUDE; MULLER, PHILIPPE; DOUBLET, FREDERIC MARC MAURICE
To: JANSSEN CILAG
Reel/Frame 020978/0354 →
Assignment of Assignor's Interest
May 21, 2008
From: ANDRIES, KOENRAAD JOZEF LODEWIJK; WILLEBRORDS, RUDY EDMOND; GEVERS, TOM VALERIUS JOSEPHA; TIMMERMAN, PHILIP MARIA MARTHA BERN
To: JANSSEN PHARMACEUTICA, N.V.
Reel/Frame 020979/0575 →
Assignment of Assignor's Interest
May 22, 2008
From: JANSSEN CILAG
To: TIBOTEC PHARMACEUTICALS, LTD.
Reel/Frame 020983/0531 →
Assignment of Assignor's Interest
May 22, 2008
From: JANSSEN PHARMACEUTICA, N.V.
To: TIBOTEC PHARMACEUTICALS, LTD.
Reel/Frame 020983/0648 →
Assignment of Assignor's Interest
Mar 24, 2009
From: QUAEDFLIEG, PETER JAN LEONARD; KESTELEYN, BART RUDOLF ROMANIE; VIJN, ROBERT JAN; LIEBREGTS, CONSTANTINUS SIMON MARIA
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 022445/0166 →